Clinical experience with everolimus (Certican): a summary.
Ponticelli
Claudio
C
IRCCS, Istituto Auxologico Italiano, Milan, Italy. claudio.ponticelli@fastwebnet.it
D065095:Calcineurin Inhibitors; D002986:Clinical Trials as Topic; D016903:Drug Monitoring; D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D020123:Sirolimus / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus